Health TrialsbyHealthPanel

Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia

ConditionsAlzheimer DiseaseDementiaPrimary Progressive AphasiaAphasiaProgressive AphasiaProgressive Aphasia in Alzheimer's Disease
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Texas at Austin

About this trial

The current study aims to examine the benefits of an education/support group program for individuals with progressive aphasia (caused by various etiologies, diagnoses) and their carepartners. The current study utilizes pre-, post-treatment, and follow-up assessments to measure effects of a psychoeducational support group and an implementation/communication skills training phase on measures of psychosocial function, communicative effectiveness and speech/language function. Analysis of study-specific surveys and semi-structured interviews will provide qualitative data regarding outcomes. Before beginning the education and support group, focus groups will be run in order to set priorities for the themes to be included in the education program. Participants will join via tele-based means if preferred and these participants may reside in the United States, or internationally including Mexico and Spain.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

speak Spanish and/or English (although participants may speak other languages in addition to Spanish and/or English)

identify as Hispanic and/or Latinx,

or their spouse/family member with PA identifies as Hispanic and/or Latinx

see and hear well enough to participate

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

  • Psychosocial educational, support group and implementation of strategies

    Behavioral

    Psychosocial educational, support group and implementation of strategies

Treatment groups

120 Participants
are divided into 1 treatment group
Group A: Treatment ConditionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Treatment/Acceptability Survey

In-house Acceptability and Perception of Change Survey

Time frame
Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

Secondary outcomes

1

Acceptability Measure

Acceptability scale for healthcare interventions (the Theoretical Framework of Acceptability based questionnaire; Sekhon et al., 2022)

Time frame
Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
2

% participants who complete intervention, % sessions completed

Adherence/receipt of intervention, 0-100, greater better

Time frame
Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
3

% completion of homework

Engagement, 0-100, greater better

Time frame
Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
4

Retention

Number of dropouts, reasons for dropout (related to intervention or not), and overall, retention rate at final assessment and follow-up; 80% is successful at the final post-treatment assessment and 80% is successful at the 2-month follow-up, 0-100, greater better

Time frame
Baseline, Immediately following treatment, Follow-up at 3-months post-treatment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Texas at Austin

Lead sponsor

The Association for Frontotemporal Degeneration

Collaborator

Source ClinicalTrials.gov
Apply now